The feasibility of Fingerprick Autologous Blood (FAB) as a novel treatment for severe dry eye disease (DED): a randomised controlled trial

Project Details

StatusFinished
Effective start/end date5/08/1730/09/19

Funding

  • National Institute for Health and Care Research: £8,190.00